These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8624771)

  • 1. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure.
    Chen CJ; Chiou HY; Chiang MH; Lin LJ; Tai TY
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):504-10. PubMed ID: 8624771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure.
    Hsueh YM; Wu WL; Huang YL; Chiou HY; Tseng CH; Chen CJ
    Atherosclerosis; 1998 Dec; 141(2):249-57. PubMed ID: 9862173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan.
    Tseng CH; Chong CK; Chen CJ; Tai TY
    Atherosclerosis; 1996 Feb; 120(1-2):125-33. PubMed ID: 8645353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan.
    Tseng CH; Chong CK; Chen CJ; Tai TY
    Angiology; 1997 Apr; 48(4):321-35. PubMed ID: 9112880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system.
    Chang CC; Ho SC; Tsai SS; Yang CY
    J Toxicol Environ Health A; 2004 Sep; 67(17):1353-61. PubMed ID: 15371236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan.
    Tseng CH; Chong CK; Tseng CP; Hsueh YM; Chiou HY; Tseng CC; Chen CJ
    Toxicol Lett; 2003 Jan; 137(1-2):15-21. PubMed ID: 12505429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological gradient between long-term arsenic exposure and carotid atherosclerosis.
    Wang CH; Jeng JS; Yip PK; Chen CL; Hsu LI; Hsueh YM; Chiou HY; Wu MM; Chen CJ
    Circulation; 2002 Apr; 105(15):1804-9. PubMed ID: 11956123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
    Chiou HY; Chiou ST; Hsu YH; Chou YL; Tseng CH; Wei ML; Chen CJ
    Am J Epidemiol; 2001 Mar; 153(5):411-8. PubMed ID: 11226969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan.
    Lamm SH; Byrd DM; Kruse MB; Feinleib M; Lai SH
    Biomed Environ Sci; 2003 Dec; 16(4):355-68. PubMed ID: 15011967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan.
    Wang SL; Li WF; Chen CJ; Huang YL; Chen JW; Chang KH; Tsai LY; Chou KM
    Sci Total Environ; 2011 Oct; 409(21):4528-35. PubMed ID: 21872294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ingested inorganic arsenic and prevalence of diabetes mellitus.
    Lai MS; Hsueh YM; Chen CJ; Shyu MP; Chen SY; Kuo TL; Wu MM; Tai TY
    Am J Epidemiol; 1994 Mar; 139(5):484-92. PubMed ID: 8154472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is colon cancer mortality related to arsenic exposure?
    Yang CY; Chang CC; Ho SC; Chiu HF
    J Toxicol Environ Health A; 2008; 71(8):533-8. PubMed ID: 18338288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality for certain diseases in areas with high levels of arsenic in drinking water.
    Tsai SM; Wang TN; Ko YC
    Arch Environ Health; 1999; 54(3):186-93. PubMed ID: 10444040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
    Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.
    Lamm SH; Robbins S; Chen R; Lu J; Goodrich B; Feinleib M
    Toxicology; 2014 Dec; 326():25-35. PubMed ID: 25241138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases.
    Wu MM; Kuo TL; Hwang YH; Chen CJ
    Am J Epidemiol; 1989 Dec; 130(6):1123-32. PubMed ID: 2589305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan.
    Chiu HF; Yang CY
    J Toxicol Environ Health A; 2005 Mar; 68(5):319-27. PubMed ID: 15799625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease.
    Chen CJ; Wu MM; Lee SS; Wang JD; Cheng SH; Wu HY
    Arteriosclerosis; 1988; 8(5):452-60. PubMed ID: 3190552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans?
    Yang CY
    J Toxicol Environ Health A; 2006 Oct; 69(19):1797-804. PubMed ID: 16905509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.